Therapeutic Antibodies – News and Features

A new type of off-the-shelf cell-based immunotherapy shows promise for B-cell lymphomas, and could make make future cellular immunotherapies less expensive and more accessible.

Researchers have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.

A new look at cancer cells: Würzburg researchers show how therapeutic antibodies work – thanks to an innovative method of super-resolution microscopy.

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

The complex interactions of the tumor–immune–gut axis can shape responses to immunotherapy in ovarian cancer, emphasizing the importance of understanding the patient's microbiome.

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, monoclonal antibody therapies and gene therapies.

A new study reveals two molecules that are critical for breast cancer survival and spread.

Researchers have built a synthetic receptor with broad potential to program cell activity, including immune response and neurological signaling.

UCLA researchers have developed a new approach to treating glioblastoma by combining genetic and functional profiling to predict tumor responses to therapies. The team showed promising results in tumor shrinkage.

RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will explore whether RNA therapeutics can realize their full potential.